-logo.jpg "ENDRA Life Sciences (Nasdaq: NDRA)"){kind=logo}
ENDRA Life Sciences (Nasdaq: NDRA)
Focused on early detection of liver disease
25 employees · est. 2009 · Ann Arbor, United States
Glycobond
The company’s first product is an assay for HCC diagnosis, HepaCheC®
1 employees · est. 2011 · Linkoping, Sweden
ENDRA Life Sciences (Nasdaq: NDRA) is the older company (2009 vs 2011); ENDRA Life Sciences (Nasdaq: NDRA) is the larger of the two.
Side-by-Side Comparison
| Metric | ENDRA Life Sciences (Nasdaq: NDRA) | Glycobond |
|---|---|---|
| Founded | ||
| Founded | 2009 older | 2011 |
| Headquarters | ||
| Headquarters | Ann Arbor, United States | Linkoping, Sweden |
| Employees | ||
| Employees | 25 larger | 1 |
| Industry | ||
| Industry | Biotechnology, Health Care, Medical Devices | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Grant |
| Total Funding | ||
| Total Funding | $8.99M | $50.00K |
| Funding Rounds | ||
| Funding Rounds | 2 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Enhanced Ultrasound Technologies, TAEUS Platform, Liver Disease Detection, Non-Alcoholic Fatty Liver Disease (NAFLD), Medical Imaging Technology, Point-of-care Diagnostics, Liver Health Monitoring, Non-invasive Diagnostics, Healthcare Cost Reduction, Early Disease Detection, Medical Device Innovation, Liver Fat Quantification, Medical Technology Startups, Healthcare Accessibility | Medical Diagnostics, Cancer Diagnosis, Liver Diseases, Carbohydrate-binding Peptides, Recombinant Technology, CE-marked Assay, HCC Diagnosis, Liver Cancer Monitoring |
| Website | ||
| Website | endrainc.com | glycobond.com |
About ENDRA Life Sciences (Nasdaq: NDRA)
ENDRA Life Sciences Inc. (NDRA) is a biotechnology company headquartered in the United States and founded in 2007. The company's focus is on early detection of liver disease, particularly Non-Alcoholic Fatty Liver Disease (NAFLD), which affects over 1 billion people globally and is estimated to cost...
About Glycobond
Glycobond is a biotechnology startup based in Sweden that utilizes recombinant technology to produce carbohydrate-binding peptides for the diagnosis and monitoring of liver diseases and cancer. Their flagship product, HepaCheC®, is a CE-marked assay designed to aid in the diagnosis of primary liver...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at ENDRA Life Sciences (Nasdaq: NDRA) and Glycobond — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at ENDRA Life Sciences (N... and Glycobond — by email.
Frequently Asked Questions
Compare ENDRA Life Sciences (Nasdaq: NDRA) with someone else
Start typing a company name or domain.